Can a daily shot help us age better? new study tests safety in seniors
NCT ID NCT07275424
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing the safety of a daily injection called elamipretide in healthy adults aged 65 to 80. The goal is to see if it is safe and tolerable, and to measure changes in blood markers, walking distance, and cognitive function. The study involves 30 participants who will receive the injection for 4 weeks and be followed for 2 more weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING, HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Washington
RECRUITINGSeattle, Washington, 98109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What really helps us age well? scientists launch major study of health factors in older adults
- New study aims to unlock secrets of healthy aging in hispanic seniors
- Can a new exercise strategy help seniors stay active for good?
- Tailored diet and exercise may boost healthy aging
- New supplement youniqor under safety review in older adults
- Happiness hacks may slow aging, new study suggests